141 related articles for article (PubMed ID: 30537064)
1. Prognostic implications of markers of the metabolic phenotype in human cutaneous melanoma.
Nájera L; Alonso-Juarranz M; Garrido M; Ballestín C; Moya L; Martínez-Díaz M; Carrillo R; Juarranz A; Rojo F; Cuezva JM; Rodríguez-Peralto JL
Br J Dermatol; 2019 Jul; 181(1):114-127. PubMed ID: 30537064
[TBL] [Abstract][Full Text] [Related]
2. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis.
Isidoro A; Casado E; Redondo A; Acebo P; Espinosa E; Alonso AM; Cejas P; Hardisson D; Fresno Vara JA; Belda-Iniesta C; González-Barón M; Cuezva JM
Carcinogenesis; 2005 Dec; 26(12):2095-104. PubMed ID: 16033770
[TBL] [Abstract][Full Text] [Related]
3. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of mitochondrial markers in mucosal and cutaneous head and neck melanomas.
Soares CD; Morais TML; Carlos R; de Almeida OP; Mariano FV; Altemani A; de Carvalho MGF; Corrêa MB; Dos Reis RRD; Amorim LS; Jorge J
Hum Pathol; 2019 Mar; 85():279-289. PubMed ID: 30468799
[TBL] [Abstract][Full Text] [Related]
5. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis.
Cuezva JM; Chen G; Alonso AM; Isidoro A; Misek DE; Hanash SM; Beer DG
Carcinogenesis; 2004 Jul; 25(7):1157-63. PubMed ID: 14963017
[TBL] [Abstract][Full Text] [Related]
6. Loss of beta-catenin expression associated with disease progression in malignant melanoma.
Kageshita T; Hamby CV; Ishihara T; Matsumoto K; Saida T; Ono T
Br J Dermatol; 2001 Aug; 145(2):210-6. PubMed ID: 11531781
[TBL] [Abstract][Full Text] [Related]
7. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma.
Maiques O; Macià A; Moreno S; Barceló C; Santacana M; Vea A; Herreros J; Gatius S; Ortega E; Valls J; Chen BJ; Llobet-Navas D; Matias-Guiu X; Cantí C; Marti RM
Br J Dermatol; 2017 May; 176(5):1247-1258. PubMed ID: 27718503
[TBL] [Abstract][Full Text] [Related]
9. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
[TBL] [Abstract][Full Text] [Related]
10. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.
Alonso SR; Ortiz P; Pollán M; Pérez-Gómez B; Sánchez L; Acuña MJ; Pajares R; Martínez-Tello FJ; Hortelano CM; Piris MA; Rodríguez-Peralto JL
Am J Pathol; 2004 Jan; 164(1):193-203. PubMed ID: 14695333
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
[TBL] [Abstract][Full Text] [Related]
15. High expression of glycolytic and pigment proteins is associated with worse clinical outcome in stage III melanoma.
Falkenius J; Lundeberg J; Johansson H; Tuominen R; Frostvik-Stolt M; Hansson J; Egyhazi Brage S
Melanoma Res; 2013 Dec; 23(6):452-60. PubMed ID: 24128789
[TBL] [Abstract][Full Text] [Related]
16. Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.
Gambichler T; Petig AL; Stockfleth E; Stücker M
Clin Exp Dermatol; 2016 Oct; 41(7):709-16. PubMed ID: 27663144
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
18. eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.
Khosravi S; Tam KJ; Ardekani GS; Martinka M; McElwee KJ; Ong CJ
J Invest Dermatol; 2015 May; 135(5):1358-1367. PubMed ID: 25562667
[TBL] [Abstract][Full Text] [Related]
19. ZNF23 Suppresses Cutaneous Melanoma Cell Malignancy via Mitochondria-Dependent Pathway.
Zhang X; Ding C; Tian H; Dong X; Meng X; Zhu W; Liu B; Wang L; Huang M; Li C
Cell Physiol Biochem; 2017; 43(1):147-157. PubMed ID: 28848158
[TBL] [Abstract][Full Text] [Related]
20. Upregulated ankyrin repeat-rich membrane spanning protein contributes to tumour progression in cutaneous melanoma.
Liao YH; Hsu SM; Yang HL; Tsai MS; Huang PH
Br J Cancer; 2011 Mar; 104(6):982-8. PubMed ID: 21343931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]